{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:55:49Z","timestamp":1789070149024,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04263-4","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T09:50:57Z","timestamp":1753091457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and CKD care delivery in African American and American Indian or Alaska Native patients: A real-world cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Kiara N.","family":"Mayhand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radica Z.","family":"Alicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey M.","family":"Kornowske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cami R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenn B.","family":"Daratha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne B.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Roland J.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex A.T.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"4263_CR1","unstructured":"United States Renal Data System. USRDS Annual Data Report: epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD; 2023. 2023."},{"issue":"5","key":"4263_CR2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048\u201350.","journal-title":"Kidney Int"},{"issue":"1","key":"4263_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","volume":"15","author":"NG Vallianou","year":"2019","unstructured":"Vallianou NG, Mitesh S, Gkogkou A, Geladari E. Chronic kidney disease and cardiovascular disease: Is there any relationship? Curr Cardiol Rev. 2019;15(1):55\u201363.","journal-title":"Curr Cardiol Rev"},{"key":"4263_CR4","unstructured":"Chronic kidney disease basics | chronic kidney disease initiative | cdc. 2022."},{"issue":"1","key":"4263_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7\u201311.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"10159","key":"4263_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet. 2018;392(10159):2052\u201390.","journal-title":"Lancet"},{"issue":"12","key":"4263_CR7","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: Challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4263_CR8","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"4263_CR9","doi-asserted-by":"publisher","first-page":"e1918169","DOI":"10.1001\/jamanetworkopen.2019.18169","volume":"2","author":"KR Tuttle","year":"2019","unstructured":"Tuttle KR, Alicic RZ, Duru OK, Jones CR, Daratha KB, Nicholas SB, et al. Clinical characteristics of and risk factors for chronic kidney disease among adults and children: An analysis of the cure-ckd registry. JAMA Netw Open. 2019;2(12):e1918169\u2013e.","journal-title":"JAMA Netw Open"},{"key":"4263_CR10","unstructured":"United States Renal Data System. USRDS Annual Data Report: epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD; 2022. 2022."},{"issue":"1","key":"4263_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12882-020-01852-3","volume":"21","author":"HO Hounkpatin","year":"2020","unstructured":"Hounkpatin HO, Fraser SDS, Honney R, Dreyer G, Brettle A, Roderick PJ. Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review. BMC Nephrol. 2020;21(1):217.","journal-title":"BMC Nephrol"},{"issue":"4","key":"4263_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4263_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/HCO.0000000000000742","volume":"35","author":"BP Deere","year":"2020","unstructured":"Deere BP, Ferdinand KC. Hypertension and race\/ethnicity. Curr Opin Cardiol. 2020;35(4):342\u201350.","journal-title":"Curr Opin Cardiol"},{"key":"4263_CR14","doi-asserted-by":"crossref","unstructured":"Bullock A, Sheff K, Hora I, Burrows NR, Benoit SR, Saydah SH, et al. Prevalence of diagnosed diabetes in american indian and alaska native adults, 2006-2017. BMJ Open Diabetes Res Care. 2020;8(1).","DOI":"10.1136\/bmjdrc-2020-001218"},{"issue":"5","key":"4263_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","volume":"102","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the american diabetes association (ADA) and kidney disease: Improving global outcomes (KDIGO). Kidney Int. 2022;102(5):974\u201389.","journal-title":"Kidney Int"},{"issue":"10","key":"4263_CR16","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1111\/dom.15194","volume":"25","author":"SB Nicholas","year":"2023","unstructured":"Nicholas SB, Daratha KB, Alicic RZ, Jones CR, Kornowske LM, Neumiller JJ, et al. Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD registry, 2019-2020. Diabetes Obes Metab. 2023;25(10):2970\u201379.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"4263_CR17","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.2337\/dc21-0529","volume":"44","author":"ST Harris","year":"2021","unstructured":"Harris ST, Patorno E, Zhuo M, Kim SC, Paik JM. Prescribing trends of antidiabetes medications in patients with type 2 diabetes and diabetic kidney disease, a cohort study. Diabetes Care. 2021;44(10):2293\u2013301.","journal-title":"Diabetes Care"},{"issue":"6","key":"4263_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/MAJ.0000000000000475","volume":"349","author":"S Shirazian","year":"2015","unstructured":"Shirazian S, Grant CD, Mujeeb S, Sharif S, Kumari P, Bhagat M, et al. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease. Am J Med Sci. 2015;349(6):510\u201315.","journal-title":"Am J Med Sci"},{"issue":"7","key":"4263_CR19","doi-asserted-by":"publisher","first-page":"e2326230","DOI":"10.1001\/jamanetworkopen.2023.26230","volume":"6","author":"CD Chu","year":"2023","unstructured":"Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, et al. Estimated prevalence and testing for albuminuria in us adults at risk for chronic kidney disease. JAMA Netw Open. 2023;6(7):e2326230\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4263_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12882-019-1558-9","volume":"20","author":"KC Norris","year":"2019","unstructured":"Norris KC, Duru OK, Alicic RZ, Daratha KB, Nicholas SB, McPherson SM, et al. Rationale and design of a multicenter chronic kidney disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD. BMC Nephrol. 2019;20(1):416.","journal-title":"BMC Nephrol"},{"issue":"12","key":"4263_CR21","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jclinepi.2015.04.002","volume":"68","author":"RG White","year":"2015","unstructured":"White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies:\u201cSTROBE-RDS\u201d statement. J Clin Epidemiol. 2015;68(12):1463\u201371.","journal-title":"J Clin Epidemiol"},{"key":"4263_CR22","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.ajpc.2021.100187","volume":"7","author":"A Sajja","year":"2021","unstructured":"Sajja A, Li HF, Spinelli KJ, Ali A, Virani SS, Martin SS, et al. A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease. Am J Prev Cardiol. 2021;7:100187.","journal-title":"Am J Prev Cardiol"},{"key":"4263_CR23","unstructured":"Team RC A language and environment for statistical computing vienna, austria2022. Available from: https:\/\/www.R-project.org."},{"issue":"3","key":"4263_CR24","first-page":"1","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1\u201367.","journal-title":"J Stat Softw"},{"issue":"5","key":"4263_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M. Building predictive models in R using the caret package. J Stat Softw. 2008;28(5):1\u201326.","journal-title":"J Stat Softw"},{"issue":"4","key":"4263_CR26","first-page":"e29","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics\u20132015 update: A report from the american heart association. Circulation. 2015;131(4):e29\u2013322.","journal-title":"Circulation"},{"issue":"9","key":"4263_CR27","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1681\/ASN.2016010027","volume":"27","author":"JM Norton","year":"2016","unstructured":"Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, et al. Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol. 2016;27(9):2576\u201395.","journal-title":"J Am Soc Nephrol"},{"key":"4263_CR28","doi-asserted-by":"crossref","unstructured":"Lee DC. Age disparities among patients with type 2 diabetes and associated rates of hospital use and diabetic complications. Prev Chronic Dis. 2019;16.","DOI":"10.5888\/pcd16.180681"},{"issue":"1","key":"4263_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2018030296","volume":"30","author":"AC Ricardo","year":"2019","unstructured":"Ricardo AC, Yang W, Sha D, Appel LJ, Chen J, Krousel-Wood M, et al. Sex-related disparities in ckd progression. J Am Soc Nephrol. 2019;30(1):137\u201346.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4263_CR30","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1089\/jwh.2009.1701","volume":"19","author":"KA Cameron","year":"2010","unstructured":"Cameron KA, Song J, Manheim LM, Dunlop DD. Gender disparities in health and healthcare use among older adults. J Womens Health (Larchmt). 2010;19(9):1643\u201350.","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"4263_CR31","doi-asserted-by":"publisher","first-page":"e015625","DOI":"10.1161\/JAHA.119.015625","volume":"9","author":"SS Bruce","year":"2020","unstructured":"Bruce SS, Merkler AE, Bassi M, Chen ML, Omran SS, Navi BB, et al. Differences in diagnostic evaluation in women and men after acute ischemic stroke. Am Heart J. 2020;9(5):e015625.","journal-title":"Am Heart J"},{"issue":"1","key":"4263_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000500706","volume":"50","author":"J Lee","year":"2019","unstructured":"Lee J, Chu C, Guzman D, Fontil V, Velasquez A, Powe NR, et al. Albuminuria testing by race and ethnicity among patients with hypertension with and without diabetes. Am J Nephrol. 2019;50(1):48\u201354.","journal-title":"Am J Nephrol"},{"issue":"7","key":"4263_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1681\/ASN.2018100971","volume":"30","author":"DP Murphy","year":"2019","unstructured":"Murphy DP, Drawz PE, Foley RN. Trends in angiotensin-converting enzyme inhibitor and angiotensin ii receptor blocker use among those with impaired kidney function in the United States. J Am Soc Nephrol. 2019;30(7):1314\u201321.","journal-title":"J Am Soc Nephrol"},{"key":"4263_CR34","doi-asserted-by":"crossref","unstructured":"Koraishy FM, Hooks-Anderson D, Salas J, Scherrer JF. Rate of renal function decline, race and referral to nephrology in a large cohort of primary care patients. Fam Pract. 2017;34(4):416\u201322.","DOI":"10.1093\/fampra\/cmx012"},{"key":"4263_CR35","doi-asserted-by":"crossref","unstructured":"Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1, Supplement):S65\u2013S71.","DOI":"10.1016\/j.chest.2020.03.012"},{"key":"4263_CR36","doi-asserted-by":"crossref","unstructured":"Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"key":"4263_CR37","doi-asserted-by":"crossref","unstructured":"Morris TP, White IR, Royston P. Tuning multiple imputation by predictive mean matching and local residual draws. BMC Med Res Methodol. 2014;14(1):75.","DOI":"10.1186\/1471-2288-14-75"},{"key":"4263_CR38","doi-asserted-by":"crossref","unstructured":"Taal MW, Selby NM. Glucagon-like peptide-1 receptor agonists: new evidence of kidney and cardiovascular protection from the FLOW and SELECT trials. Am J Kidney Dis. 2025;85(1):115\u20138.","DOI":"10.1053\/j.ajkd.2024.08.002"},{"key":"4263_CR39","doi-asserted-by":"crossref","unstructured":"Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021;398(10296):262\u201376.","DOI":"10.1016\/S0140-6736(21)00536-5"},{"key":"4263_CR40","doi-asserted-by":"crossref","unstructured":"Yau K, Dharia A, Alrowiyti I, Cherney DZI. Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations. Kidney Int Rep. 2022;7(7):1463\u201376.","DOI":"10.1016\/j.ekir.2022.04.094"},{"key":"4263_CR41","doi-asserted-by":"crossref","unstructured":"Nicholas SB, Alicic RZ, Shen J. Disparities in the use of SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with CKD in the United States. Kidney Med. 2023;5(1):100590.","DOI":"10.1016\/j.xkme.2022.100590"},{"key":"4263_CR42","doi-asserted-by":"crossref","unstructured":"Zhao JZ, Weinhandl ED, Carlson AM, St Peter WL. Disparities in SGLT2 inhibitor or glucagon-like peptide 1 receptor agonist initiation among medicare-insured adults with CKD in the United States. Kidney Med. 2023;5(1):100564.","DOI":"10.1016\/j.xkme.2022.100564"},{"key":"4263_CR43","doi-asserted-by":"crossref","unstructured":"Eberly LA, Yang L, Eneanya ND, Essien U, Julien H, Nathan AS, et al. Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US. JAMA Netw Open. 2021;4(4):e216139.","DOI":"10.1001\/jamanetworkopen.2021.6139"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04263-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:24:11Z","timestamp":1757262251000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4263"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04263-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were approved by Providence (Washington, Montana, Oregon, Alaska, California), the University of California, Los Angeles (UCLA; California), and Johns Hopkins University (JHU; Maryland) Institutional Review Boards that operate in full accordance with institutional, state, and national policies and regulations for human research participants and the principles of the Declaration of Helsinki. The Institutional Review Boards determined that obtaining written informed consent was not required due to use of a limited dataset. Data use agreements between Providence, UCLA and JHU were established to provide the necessary framework for data sharing, stewardship, and security.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}